No additive effect of fibrin sealants to tranexamic acid in perioperative blood conservation in total knee arthroplasty

No additive effect of fibrin sealants to tranexamic acid in perioperative blood conservation in total knee arthroplasty

Authors

  • Remo Goderecci Unit of Orthopaedics and Traumatology, G. Mazzini Hospital, Teramo https://orcid.org/0000-0003-0390-5975
  • Giuseppe Aloisi Department of Life, Health and Environmental Sciences, University of L’Aquila https://orcid.org/0000-0003-1470-7253
  • Giovanni Giorgio Caschera Unit of Orthopaedics and Traumatology, G. Mazzini Hospital, Teramo
  • Alessandro Paglia Unit of Orthopaedics and Traumatology, G. Mazzini Hospital, Teramo
  • Giuseppe Petralia Department of Life, Health and Environmental Sciences, University of L’Aquila
  • Luca Gagliardi Department of Orthopaedics, University of Torino
  • Michela Saracco Department of Orthopaedics, San Giovanni di Dio Hospital, Napoli https://orcid.org/0000-0003-2190-9574
  • Stefano Necozione Department of Life, Health and Environmental Sciences, University of L’Aquila https://orcid.org/0000-0003-2501-1665
  • Giandomenico Logroscino Department of Life, Health and Environmental Sciences, University of L’Aquila https://orcid.org/0000-0003-1301-5343

Keywords:

Total knee arthroplasty, blood loss, tranexamic acid, fibrin tissue adhesive, blood conservation

Abstract

Background: Total knee arthroplasty (TKA) is associated with significant blood loss and reducing allogenic blood transfusions remains a challenge for the orthopedic surgeons. Between the various methods of blood conservation, the most appropriate solution is to reduce the loss of blood during and after surgery.

Materials and methods: This prospective, randomized, standard treatment-controlled trial is based on the evaluation of the hemostatic efficacy of fibrin tissue sealant in association with tranexamic acid (TXA) in patients undergoing TKA.

Sixty patients were scheduled to receive a TKA and randomly divided into two groups: a control group (30 patients), in which the standard means of hemostasis were applied, including the intraoperative intravenous administration of 1 g of TXA, and a treatment group (30 patients), in which the same standard method to control bleeding was used and, in addition to the TXA administration, a fibrin tissue adhesive was sprayed locally during the operation.

Results: The main outcome of the study was the evaluation of postoperative levels of hemoglobin (Hb), red blood cells (RBC), and hematocrit (Ht) at 3 hours and on the first, the third and the sixth days after surgery. We found a slight decrease in Hb, RBC and Ht levels in the treatment group, but the difference was not statistically significant. The recovery of the knee range of motion on the first and the third postoperative day was lower in the treatment group compared although also this difference was not significant. No substantial difference in the grade of postoperative pain was recorded. In no case allogenic blood transfusions were necessary. No major adverse events were registered in our series.

Conclusions: The use of fibrin sealant (FS) did not produce significant benefits compared to the isolated use of TXA.

References

1. Sizer SC, Cherian JJ, Elmallah RD, et al. Predicting blood loss in total knee and hip arthroplasty. Orthop Clin North Am. 2015;46:445-59. doi: 10.1016/j.ocl.2015.06.002.

2. Cundy WJ, Theodoulou A, Ling CM, Krishnan J, Wilson CJ. Blood loss in total knee arthroplasty. J Knee Surg. 2017;30(5):452-9. doi: 10.1055/s-0036-1592147.

3. Chan PK, Hwang YY, Cheung A, et al. Blood transfusions in total knee arthroplasty: a retrospective analysis of a multimodal patient blood management programme. Hong Kong Med J. 2020;26(3):201-7. doi: 10.12809/hkmj198289.

4. Hart A, Khalil JA, Carli A, et al. Blood transfusion in primary total hip and knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am. 2014;96:1945-51. doi: 10.2106/JBJS.N.00077.

5. Browne JA, Adib F, Brown TE, et al. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28:34-7. doi: 10.1016/j.arth.2013.03.035.

6. Kato H, Nakayama T, Uruma M, et al. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history. Vox Sang. 2015;108:243-50. doi: 10.1111/vox.12208.

7. Banerjee S, Issa K, Kapadia BH, et al. Intraoperative nonpharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg. 2013;26:387-93. doi: 10.1055/s-0033-1353993.

8. Bedair H, Yang J, Dwyer MK, McCarthy JC. Preoperative erythropoietin alpha reduces postoperative transfusions in THA and TKA but may not be cost-effective. Clin Orthop Relat Res. 2015;473(2):590-6. doi: 10.1007/s11999-014-3819-z.

9. Jung WH, Chun CW, Lee JH, et al. No difference in total blood loss, hemoglobin and hematocrit between continuous and intermittent wound drainage after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2013;21:2831-6. doi: 10.1007/s00167-012-2253-6.

10. Su EP, Su S. Strategies for reducing peri-operative blood loss in total knee arthroplasty. Bone Joint J. 2016;98-B(1 Suppl A):98-100. doi: 10.1302/0301-620X.98B.36430.

11. Thienpont E, Grosu I, Paternostre F, et al. The use of patient-specific instruments does not reduce blood loss during minimally invasive total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2015;23:2055-60. doi: 10.1007/s00167-014-2952-2.

12. Jiang FZ, Zhong HM, Hong YC, et al. Use of a tourniquet in total knee arthroplasty: a systematic review and meta-analysis of randomized controlled trials. J Orthop Sci. 2015;20:110-23. doi: 10.1007/s00776-014-0664-6.

13. Parvizi J, Diaz-Ledezma C. Total knee replacement with the use of a tourniquet: more pros than cons. Bone Joint J. 2013;95-B(11 Suppl A):133-4. doi: 10.1302/0301-620X.95B11.32903.

14. Aguilera X, Martinez-Zapata MJ, Hinarejos P, et al. Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trial. Arch Orthop Trauma Surg. 2015;135:1017-25. doi: 10.1007/s00402-015-2232-8.

15. Alshryda S, Sukeik M, Sarda P, et al. A systematic review and meta-analysis of the topical administration of tranexamic acid in total hip and knee replacement. Bone Joint J. 2014;96-B:1005-15. doi: 10.1302/0301-620X.96B8.33745.

16. Kim TK, Chang CB, Koh IJ. Practical issues for the use of tranexamic acid in total knee arthroplasty: a systematic review. Knee Surg Sports Traumatol Arthrosc. 2014;22:1849-58. doi: 10.1007/s00167-013-2487-y.

17. Zhao-Yu C, Yan G, Wei C, et al. Reduced blood loss after intra-articular tranexamic acid injection during total knee arthroplasty: a meta-analysis of the literature. Knee Surg Sports Traumatol Arthrosc. 2014;22:3181-90. doi: 10.1007/s00167-013-2814-3.

18. Goderecci R, Giusti I, Necozione S, Cinque B, D'Ascenzo S, Dolo V, Calvisi V. Short exposure to tranexamic acid does not affect, in vitro, the viability of human chondrocytes. Eur J Med Res. 2019;24:15. doi: 10.1186/s40001-019-0373-x.

19. Bernasek TL, Burris RB, Fujii H, et al. Effect on blood loss and cost-effectiveness of pain cocktails, platelet-rich plasma, or fibrin sealant after total knee arthroplasty. J Arthroplasty. 2012;27:1448-51. doi: 10.1016/j.arth.2012.02.018.

20. Randelli F, D'Anchise R, Ragone V, et al. Is the newest fibrin sealant an effective strategy to reduce blood loss after total knee arthroplasty? A randomized controlled study. J Arthroplasty. 2014;29:1516-20. doi: 10.1016/j.arth.2014.02.024.

21. Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ. The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty. 2018;33:3090-8.e1. doi: 10.1016/j.arth.2018.04.043.

22. Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ. Tranexamic acid in total joint arthroplasty: the endorsed clinical practice guides of the American Association of Hip and Knee Surgeons, American Society of Regional Anaesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society. Reg Anesth Pain Med. 2019;44:7-11. doi: 10.1136/rapm-2018-000024.

23. Jackson MR. Fibrin sealants in surgical practice: an overview. Am J Surg. 2001;182(2 Suppl):1S-7S. doi: 10.1016/s0002-9610(01)00770-x.

24. Li ZJ, Fu X, Tian P, et al. Fibrin sealant before wound closure in total knee arthroplasty reduced blood loss: a meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2015;23:2019-25. doi: 10.1007/s00167-014-2898-4.

25. Wang GJ, Hungerford DS, Savory CG, Rosenberg AG, Mont MA, Burks SG, Mayers SL, Spotnitz WD. Use of fibrin sealant to reduce bloody drainage and hemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. J Bone Joint Surg Am. 2001;83:1503-5. doi: 10.2106/00004623-200110000-00007.

26. Fan YY, Deng B, Hong HN, et al. The efficacy and safety of fibrin sealant versus tranexamic acid administration in patients undergoing hip arthroplasty: a meta-analysis. 06 November 2020, PREPRINT (Version 1) available at Research Square. doi: 10.21203/rs.3.rs-101441/v1.

27. Calvisi V, Paglia A, Ciprietti N, Goderecci R. Cruciate-retaining total knee arthroplasty [Internet]. Primary Total Knee Arthroplasty. InTech; 2018. doi: 10.5772/intechopen.74024.

28. Paglia A, Goderecci R, Ciprietti N, Lagorio M, Necozione S, Calvisi V. Pain management after total knee arthroplasty: a prospective randomized study. J Clin Orthop Trauma. 2020;11:113-7. doi: 10.1016/j.jcot.2018.12.005.

29. Bell TH, Berta D, Ralley F, Macdonald SJ, McCalden RW, Bourne RB, Rorabeck CH, Naudie DD. Factors affecting perioperative blood loss and transfusion rates in primary total joint arthroplasty: a prospective analysis of 1642 patients. Can J Surg. 2009;52:295-301. PMID: 19680514.

30. Maheshwari AV, Korshunov Y, Naziri Q, Pivec R, Mont MA, Rasquinha VJ. No additional benefit with use of a fibrin sealant to decrease peri-operative blood loss during primary total knee arthroplasty. J Arthroplasty. 2014;29:2109-12. doi: 10.1016/j.arth.2014.02.034.

31. Yang TQ, Geng XL, Ding MC, Yang MX, Zhang Q. The efficacy of fibrin sealant in knee surgery: a meta-analysis. Orthop Traumatol Surg Res. 2015;101:331-9. doi: 10.1016/j.otsr.2014.07.035.

32. Notarnicola A, Moretti L, Martucci A, Spinarelli A, Tafuri S, Pesce V, Moretti B. Comparative efficacy of different doses of fibrin sealant to reduce bleeding after total knee arthroplasty. Blood Coagul Fibrinolysis. 2012;23:278-84. doi: 10.1097/MBC.0b013e3283518846.

33. Kluba T, Fiedler K, Kunze B, Ipach I, Suckel A. Fibrin sealants in orthopaedic surgery: practical experiences derived from use of QUIXIL® in total knee arthroplasty. Arch Orthop Trauma Surg. 2012;132:1147-52. doi: 10.1007/s00402-012-1519-2.

34. Tarantino A, Romanini E, Venosa M, Torre M, Schettini I, Goderecci R, Logroscino G, Calvisi V. Italian arthroplasty registry: learning curve and optimization of data entry procedures. Recenti Prog Med. 2020;111:327-30. doi: 10.1701/3366.33414.

35. Presutti M, Goderecci R, Palumbo P, Giannetti A, Mazzoleni MG, Randelli FM, Angelozzi M, Calvisi V, Fidanza A. A novel biplanar medial opening-wedge high tibial osteotomy: the Z-shaped technique. A case series at 7.2 years follow-up. J Orthop Traumatol. 2021;22:53. doi: 10.1186/s10195-021-00617-4.

36. Scardino M, Martorelli F, D'Amato T, Fenocchio G, Simili V, Grappiolo G, Di Matteo B, Kon E, Lagioia M. Use of a fibrin sealant within a blood-saving protocol in patients undergoing revision hip arthroplasty: effects on post-operative blood transfusion and healthcare-related cost analysis. Int Orthop. 2019;43:2707-14. doi: 10.1007/s00264-019-04291-4.

37. Verra WC, van Hilten JA, Honohan Á, van Zwet EW, van der Bom JG, Nelissen RGHH; FIRST-research group. The effect of a fibrin sealant on knee function after total knee replacement surgery. Results from the FIRST trial. A multicenter randomized controlled trial. PLoS One. 2018;13:e0200804. doi: 10.1371/journal.pone.0200804.

38. Haratian A, Shelby T, Hasan LK, Bolia IK, Weber AE, Petrigliano FA. Utilization of tranexamic acid in surgical orthopaedic practice: indications and current considerations. Orthop Res Rev. 2021;13:187-99. doi: 10.2147/ORR.S321881.

39. Gao F, Ma J, Sun W, Guo W, Li Z, Wang W. Topical fibrin sealant versus intravenous tranexamic acid for reducing blood loss following total knee arthroplasty: a systematic review and meta-analysis. Int J Surg. 2016;32:31-7. doi: 10.1016/j.ijsu.2016.06.009.

40. Dong Z, Han L, Song Y, Qi J, Wang F. Haemostatic techniques to reduce blood transfusion after primary TKA: a meta-analysis and systematic review. Arch Orthop Trauma Surg. 2019;139:1785-96. doi: 10.1007/s00402-019-03271-y.

41. Bernasek TL, Burris RB, Fujii H, Levering MF, Polikandriotis JA, Patterson JJ. Effect on blood loss and cost-effectiveness of pain cocktails, platelet-rich plasma, or fibrin sealant after total knee arthroplasty. J Arthroplasty. 2012;27:1448-51. doi: 10.1016/j.arth.2012.02.018.

Downloads

Published

23-06-2025

Issue

Section

ORTHOPAEDICS AND SURGERY

How to Cite

1.
Goderecci R, Aloisi G, Caschera GG, et al. No additive effect of fibrin sealants to tranexamic acid in perioperative blood conservation in total knee arthroplasty. Acta Biomed. 2025;96(3):16199. doi:10.23750/abm.v96i3.16199